loadpatents
name:-0.038349866867065
name:-0.043102979660034
name:-0.003978967666626
CARNIATO; DENIS Patent Filings

CARNIATO; DENIS

Patent Applications and Registrations

Patent applications and USPTO patent grants for CARNIATO; DENIS.The latest application filed is for "bioadhesive particles comprising active agents, and uses thereof".

Company Profile
2.43.28
  • CARNIATO; DENIS - MARCOUSSIS FR
  • Carniato; Denis - Antony N/A FR
  • Carniato; Denis - Cagnes sur Mer FR
  • Carniato; Denis - Clamart FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bioadhesive Particles Comprising Active Agents, And Uses Thereof
App 20220273530 - POULETTY; PHILIPPE ;   et al.
2022-09-01
Derivatives of indole for the treatment of cancer, viral infections and lung diseases
Grant 10,851,054 - Bougeret , et al. December 1, 2
2020-12-01
New Derivatives Of Indole For The Treatment Of Cancer, Viral Infections And Lung Diseases
App 20190169124 - BOUGERET; CECILE ;   et al.
2019-06-06
Bicyclic lipolantipeptide, preparation and use as antimicrobial agent
Grant 10,308,683 - Aszodi , et al.
2019-06-04
Derivatives of indole for the treatment of cancer, viral infections and lung diseases
Grant 10,189,782 - Bougeret , et al. Ja
2019-01-29
New Bicyclic Lipolantipeptide, Preparation And Use As Antimicrobial Agent
App 20180201646 - ASZODI; JOSEF ;   et al.
2018-07-19
Piperazinyl derivatives for the treatment of cancer
Grant 9,877,962 - Carniato , et al. January 30, 2
2018-01-30
New Derivatives Of Indole For The Treatment Of Cancer, Viral Infections And Lung Diseases
App 20170233342 - BOUGERET; CECILE ;   et al.
2017-08-17
Derivatives of indole for the treatment of cancer, viral infections and lung diseases
Grant 9,643,923 - Bougeret , et al. May 9, 2
2017-05-09
Piperazinyl Derivatives For The Treatment Of Cancer
App 20160237042 - CARNIATO; Denis ;   et al.
2016-08-18
Piperazinyl derivatives for the treatment of cancer
Grant 9,321,778 - Carniato , et al. April 26, 2
2016-04-26
New Derivatives Of Indole For The Treatment Of Cancer, Viral Infections And Lung Diseases
App 20150307450 - Bougeret; Cecile ;   et al.
2015-10-29
Piperazinyl Derivatives For The Treatment Of Cancer
App 20140356360 - Carniato; Denis ;   et al.
2014-12-04
Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
Grant 8,673,955 - Carniato , et al. March 18, 2
2014-03-18
Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors
Grant 8,586,577 - Carniato , et al. November 19, 2
2013-11-19
NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1
Grant 8,546,575 - Leriche , et al. October 1, 2
2013-10-01
Compounds which can be used for the treatment of cancers
Grant 8,519,188 - Carniato , et al. August 27, 2
2013-08-27
Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
Grant 8,486,964 - Valeur , et al. July 16, 2
2013-07-16
7-azaindole derivatives as selective 11-.beta.-hydroxysteroid dehydrogenase type 1 inhibitors
Grant 8,470,849 - Carniato , et al. June 25, 2
2013-06-25
2-adamantylurea derivatives as selective 11.beta.-HSD1 inhibitors
Grant 8,466,200 - Carniato , et al. June 18, 2
2013-06-18
Diazepane Acetamide Derivatives As Selective 11b-hsd1 Inhibitors
App 20120283247 - CARNIATO; Denis ;   et al.
2012-11-08
Diazepane-acetamide derivatives as selective 11.beta.-HSD1 inhibitors
Grant 8,242,107 - Carniato , et al. August 14, 2
2012-08-14
N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
Grant 8,236,824 - Burgdorf , et al. August 7, 2
2012-08-07
2-adamantylurea Derivatives As Selective 11b-hsd1 Inhibitors
App 20120172396 - CARNIATO; Denis ;   et al.
2012-07-05
2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
Grant 8,188,288 - Carniato , et al. May 29, 2
2012-05-29
2-adamantyl-butyramide derivatives as selective 11.beta.-HSD1 inhibitors
Grant 8,183,265 - Roche , et al. May 22, 2
2012-05-22
Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
App 20110172265 - Valeur; Eric ;   et al.
2011-07-14
Compounds which can be used for the Treatment of Cancers
App 20110104162 - Carniato; Denis ;   et al.
2011-05-05
Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1
App 20110060007 - Leriche; Caroline ;   et al.
2011-03-10
7-Azaindole Derivatives as Selective 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
App 20100267761 - Carniato; Denis ;   et al.
2010-10-21
N-(pyrazole-3-yl)-benzamide Derivatives As Glucokinase Activators
App 20100210690 - Burgdorf; Lars Thore ;   et al.
2010-08-19
Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors
App 20100069365 - Carniato; Denis ;   et al.
2010-03-18
2-adamantyl-butyramide Derivatives As Selective 11beta-hsd1 Inhibitors
App 20100022597 - Roche; Didier ;   et al.
2010-01-28
2-adamantylurea Derivatives As Selective 11beta-hsd1 Inhibitors
App 20090227631 - Carniato; Denis ;   et al.
2009-09-10
Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
Grant 7,476,691 - Lafay , et al. January 13, 2
2009-01-13
Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them
App 20080312299 - Carniato; Denis ;   et al.
2008-12-18
Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
Grant 7,348,333 - Wehner , et al. March 25, 2
2008-03-25
Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
App 20080021055 - Wehner; Volkmar ;   et al.
2008-01-24
Vitronectin receptor antagonists, their preparation and their use
Grant 6,867,208 - Wehner , et al. March 15, 2
2005-03-15
5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
Grant 6,803,380 - Pascal , et al. October 12, 2
2004-10-12
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
Grant 6,747,148 - Peyman , et al. June 8, 2
2004-06-08
1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them
Grant 6,737,433 - Adje , et al. May 18, 2
2004-05-18
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
Grant 6,723,727 - Peyman , et al. April 20, 2
2004-04-20
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
Grant 6,660,728 - Scheunemann , et al. December 9, 2
2003-12-09
Inhibitors of bone reabsorption and antagonists of vitronectin receptors
Grant 6,620,820 - Wehner , et al. September 16, 2
2003-09-16
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
App 20030153557 - Scheunemann, Karl-Heinz ;   et al.
2003-08-14
Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
Grant 6,602,878 - Carniato , et al. August 5, 2
2003-08-05
Vitronectin receptor antagonists, their preparation and use
App 20030119785 - Wehner, Volkmar ;   et al.
2003-06-26
Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
App 20030050314 - Wehner, Volkmar ;   et al.
2003-03-13
Vitronectin receptor antagonists, their preparation and their use
App 20030027807 - Wehner, Volkmar ;   et al.
2003-02-06
New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
App 20020187976 - Carniato, Denis ;   et al.
2002-12-12
Vitronectin receptor antagonists, their preparation and their use
Grant 6,482,821 - Wehner , et al. November 19, 2
2002-11-19
Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
Grant 6,458,801 - Carniato , et al. October 1, 2
2002-10-01
Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
App 20020119999 - Wehner, Volkmar ;   et al.
2002-08-29
Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists
Grant 6,399,620 - Wehner , et al. June 4, 2
2002-06-04
Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
App 20020065271 - Peyman, Anuschirwan ;   et al.
2002-05-30
Vitronectin receptor antagonists, their preparation and their use
Grant 6,387,895 - Wehner , et al. May 14, 2
2002-05-14
Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
App 20010021708 - Wehner, Volkmar ;   et al.
2001-09-13
Vitronectin receptor antagonists, their preparation and their use
App 20010011087 - Wehner, Volkmar ;   et al.
2001-08-02
Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same
Grant 6,221,907 - Bernard , et al. April 24, 2
2001-04-24
Vitronectin receptor antagonists, their preparation and their use
Grant 6,011,045 - Wehner , et al. January 4, 2
2000-01-04
Imino compounds, process for their preparation and their use as victronectin antagonists
Grant 6,005,117 - Wehner , et al. December 21, 1
1999-12-21
Vitronectin receptor antagonists, their preparation and their use
Grant 5,990,145 - Wehner , et al. November 23, 1
1999-11-23
Guanidinoalkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
Grant 5,294,608 - Lang , et al. March 15, 1
1994-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed